Opus Genetics (IRD) Operating Income Growth (1y) (2011 - 2026)
Opus Genetics (IRD) Operating Income Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 8.32% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 19.82% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 145.20% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 269.85% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 76.24% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -36.55% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1,528.74% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 99.51% |
| 10 | Opus Genetics | 298.36 Mn | 209.55 Mn | - | -85.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -85.04% |
| Mar 31, 2026 | -44.67% |
| Dec 31, 2025 | 69.88% |
| Sep 30, 2025 | -3.77% |
| Jun 30, 2025 | -6.94% |
| Mar 31, 2025 | -28.81% |
| Dec 31, 2024 | -600.48% |
| Sep 30, 2024 | -225.41% |
| Jun 30, 2024 | -54.54% |
| Mar 31, 2024 | -25.72% |
| Dec 31, 2023 | -115.87% |
| Sep 30, 2023 | 240.72% |
| Jun 30, 2023 | -9.13% |
| Mar 31, 2023 | 5.79% |
| Dec 31, 2022 | 656.26% |
| Sep 30, 2022 | -7.23% |
| Jun 30, 2022 | 30.81% |
| Mar 31, 2022 | -25.49% |
| Dec 31, 2021 | 56.14% |
| Sep 30, 2021 | -117.25% |